Ujiie H - Search Results

1

The relevance of complement in pemphigoid diseases: A critical appraisal.

Papara C, Karsten CM, Ujiie H, Schmidt E, Schmidt-Jiménez LF, Baican A, Freire PC, Izumi K, Bieber K, Peipp M, Verschoor A, Ludwig RJ, Köhl J, Zillikens D, Hammers CM. Papara C, et al. Among authors: ujiie h. Front Immunol. 2022 Aug 16;13:973702. doi: 10.3389/fimmu.2022.973702. eCollection 2022. Front Immunol. 2022. PMID: 36059476 Free PMC article. Review.

2

A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies.

Nishie W, Sawamura D, Natsuga K, Shinkuma S, Goto M, Shibaki A, Ujiie H, Olasz E, Yancey KB, Shimizu H. Nishie W, et al. Among authors: ujiie h. J Immunol. 2009 Sep 15;183(6):4088-93. doi: 10.4049/jimmunol.0800389. Epub 2009 Aug 28. J Immunol. 2009. PMID: 19717520

3

A novel active mouse model for bullous pemphigoid targeting humanized pathogenic antigen.

Ujiie H, Shibaki A, Nishie W, Sawamura D, Wang G, Tateishi Y, Li Q, Moriuchi R, Qiao H, Nakamura H, Akiyama M, Shimizu H. Ujiie H, et al. J Immunol. 2010 Feb 15;184(4):2166-74. doi: 10.4049/jimmunol.0903101. Epub 2010 Jan 20. J Immunol. 2010. PMID: 20089696

4

What's new in bullous pemphigoid.

Ujiie H, Shibaki A, Nishie W, Shimizu H. Ujiie H, et al. J Dermatol. 2010 Mar;37(3):194-204. doi: 10.1111/j.1346-8138.2009.00792.x. J Dermatol. 2010. PMID: 20507382 Review.

5

Human IgG1 monoclonal antibody against human collagen 17 noncollagenous 16A domain induces blisters via complement activation in experimental bullous pemphigoid model.

Li Q, Ujiie H, Shibaki A, Wang G, Moriuchi R, Qiao HJ, Morioka H, Shinkuma S, Natsuga K, Long HA, Nishie W, Shimizu H. Li Q, et al. Among authors: ujiie h. J Immunol. 2010 Dec 15;185(12):7746-55. doi: 10.4049/jimmunol.1000667. Epub 2010 Nov 12. J Immunol. 2010. PMID: 21076071

6

Pathogenesis of bullous pemphigoid.

Ujiie H, Nishie W, Shimizu H. Ujiie H, et al. Dermatol Clin. 2011 Jul;29(3):439-46, ix. doi: 10.1016/j.det.2011.03.008. Dermatol Clin. 2011. PMID: 21605809 Review.

7

Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.

Ujiie H, Shibaki A, Nishie W, Shinkuma S, Moriuchi R, Qiao H, Shimizu H. Ujiie H, et al. Clin Immunol. 2012 Feb;142(2):167-75. doi: 10.1016/j.clim.2011.10.002. Epub 2011 Oct 17. Clin Immunol. 2012. PMID: 22044750

8

Mucous membrane pemphigoid with generalized blisters: IgA and IgG autoantibodies target both laminin-332 and type XVII collagen.

Hayashi I, Shinkuma S, Shimizu S, Natsuga K, Ujiie H, Yasui C, Tsuchiya K, Nishie W, Shimizu H. Hayashi I, et al. Among authors: ujiie h. Br J Dermatol. 2012 May;166(5):1116-20. doi: 10.1111/j.1365-2133.2011.10776.x. Epub 2012 Mar 14. Br J Dermatol. 2012. PMID: 22182184

9

Antibodies to pathogenic epitopes on type XVII collagen cause skin fragility in a complement-dependent and -independent manner.

Natsuga K, Nishie W, Shinkuma S, Ujiie H, Nishimura M, Sawamura D, Shimizu H. Natsuga K, et al. Among authors: ujiie h. J Immunol. 2012 Jun 1;188(11):5792-9. doi: 10.4049/jimmunol.1003402. Epub 2012 Apr 20. J Immunol. 2012. PMID: 22523387

10

Pathogenesis of bullous pemphigoid.

Ujiie H, Nishie W, Shimizu H. Ujiie H, et al. Immunol Allergy Clin North Am. 2012 May;32(2):207-15, v. doi: 10.1016/j.iac.2012.04.001. Epub 2012 Apr 17. Immunol Allergy Clin North Am. 2012. PMID: 22560134

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

406 results

Search Page